No abstract available
MeSH terms
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / pharmacology
-
Antiviral Agents / therapeutic use*
-
COVID-19 / virology
-
COVID-19 Drug Treatment*
-
Clinical Trials as Topic
-
Coronavirus Protease Inhibitors / administration & dosage
-
Coronavirus Protease Inhibitors / pharmacology
-
Coronavirus Protease Inhibitors / therapeutic use*
-
Cytidine / administration & dosage
-
Cytidine / analogs & derivatives
-
Cytidine / pharmacology
-
Cytidine / therapeutic use
-
Humans
-
Hydroxylamines / administration & dosage
-
Hydroxylamines / pharmacology
-
Hydroxylamines / therapeutic use
-
Lactams / administration & dosage
-
Lactams / pharmacology
-
Lactams / therapeutic use*
-
Leucine / administration & dosage
-
Leucine / pharmacology
-
Leucine / therapeutic use*
-
Nitriles / administration & dosage
-
Nitriles / pharmacology
-
Nitriles / therapeutic use*
-
Proline / administration & dosage
-
Proline / pharmacology
-
Proline / therapeutic use*
-
Ritonavir / administration & dosage
-
Ritonavir / pharmacology
-
Ritonavir / therapeutic use*
-
SARS-CoV-2 / drug effects
-
Tablets
Substances
-
Antiviral Agents
-
Coronavirus Protease Inhibitors
-
Hydroxylamines
-
Lactams
-
Nitriles
-
Tablets
-
nirmatrelvir and ritonavir drug combination
-
Cytidine
-
Proline
-
Leucine
-
Ritonavir
-
molnupiravir